GNLX

Genelux Corporation - Common Stock (GNLX)

About Genelux Corporation - Common Stock (GNLX)

Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay on September 4, 2001 and is headquartered in Westlake Village, CA.

Details

Daily high

$2.58

Daily low

$2.51

Price at open

$2.57

52 Week High

$8.54

52 Week Low

$2.29

Market cap

114.5M

Dividend yield

Volume

197,287

Avg. volume

332,682

P/E ratio

-2.92

Genelux Corporation - Common Stock News